Guo LF, Rao MY, Yu YF, Lin Q, et al. The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy. BMC Cancer 2024;24:950.
PMID: 39095737